Table 2.
Adverse drug reaction | Denosumab Group n (%) |
Alendronate Group n (%) |
---|---|---|
Hypocalcemia | 3 (9.7) | 0 |
Eczema | 1 (3.2) | 2 (6.4) |
Urticaria | 1 (3.2) | 4 (12.9) |
Rash | 2 (6.4) | 3 (9.7) |
Abdominal discomfort | 3 (9.7) | 1 (3.2) |
Nausea | 1 (3.2) | 1 (3.2) |
Decreased appetite | 3 (9.7) | 1 (3.2) |
Headache | 1 (3.2) | 4 (12.9) |